Recent Material Events - Unigene Labs, Inc (UGNE)

Filing Date	Description
2008-10-06	Pursuant to the Financing Agreement, the Company issued to the Lenders 1,125,000 shares (the “First Closing Shares”) of its common stock, par value $0.01 per share (the “Common Stock”). In addition, the Company will issue to the L ...
2007-11-13	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2007-03-19	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.... ...
2007-03-01	Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.... ...
2007-02-14	On February 8, 2007, the Board reviewed the recommendations of the Compensation Committee and approved material increases to the annual salaries of Drs. Levy. Dr. Warren Levy’s annual salary increased fourteen percent (14%) to $285,000 and Dr. R... ...
2007-01-29	On January 26, 2007, Unigene Laboratories, Inc. (the “Company”) entered into an Agreement (the “Agreement”), with an effective date as of January 22, 2007, between the Company and Novartis Pharma AG (“Novartis”). Pursuan... ...
2006-12-18	(e) On December 12, 2006, the Board of Directors (the “Board”) of Unigene Laboratories, Inc. (the “Company”) reviewed the recommendations of the Board’s Compensation Committee and approved bonuses for 2006 (the “Bonuses&... ...